Title Image

Press Releases

LSKB Attending ASCO 2016 annual meeting

LSKB is attending ASCO in Chicago at the McCormick Center June 2-7th. We will be meeting with key leading oncologists from across the globe to discuss late stage development of apatinib mesylate in gastric cancer, colorectal cancer, and hepatocellular carcinoma. Contact arlo.mcginn@lskbiopharma.com for more information.

PREV

LSKB Attending Bio Europe Spring in Stockholm

NEXT

LSKB Attending Bio International Convention in San Francisco